Loading chat...
MI HB5045
Bill
Status
10/8/2019
Primary Sponsor
Henry Vaupel
Click for details
AI Summary
HB 5045 Summary
-
Adds an exemption to Michigan's controlled substance prescription monitoring requirements for controlled substances approved by the FDA to treat epilepsy or seizure disorders.
-
Defines "epilepsy or seizure disorder" to include neurological diseases with recurrent unprovoked seizures, diagnosed epilepsy syndromes, and brain conditions causing seizure activity regardless of onset origin.
-
Exempts prescribers from the requirement to obtain and review reports from the electronic prescription monitoring system (MAPS) before prescribing epilepsy/seizure medications in excess of a 3-day supply.
-
Takes effect 90 days after enactment into law.
Legislative Description
Health; pharmaceuticals; requirement to obtain and review a report from the Michigan automated prescription system (MAPS); exempt certain controlled substances for the treatment of epilepsy or seizure disorders. Amends sec. 7303a of 1978 PA 368 (MCL 333.7303a).
Health: controlled substances
Last Action
Bill Electronically Reproduced 10/10/2019
10/10/2019